In terms of diagnosis, immunohistochemical analysis of prostate cancer specimens with a range of Gleason scores revealed that STEAP1 could be a suitable candidate to distinguish patients with cancer from patients without tumor (15). Here, STEAP1 is linked to Familial prostate cancer.